Pharmaceutical Dissolution Testing Services Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Services Method, By Dissolution Apparatus, By Dosage Form, By Region & Competition, 2021-2031F

Description

The Global Pharmaceutical Dissolution Testing Services Market is forecast to expand significantly, from USD 761.39 Million in 2025 to USD 1257.37 Million by 2031, at an 8.72% CAGR. These services involve outsourced analytical evaluations of drug release rates under simulated physiological conditions, driven by increasing demands for bioequivalence studies and stringent global regulatory quality control mandates. North America's substantial pharmaceutical sales, representing 54.8% of the global total in 2024, underscore the immense volume of products requiring comprehensive quality verification. However, a key impediment to market scalability is the acute scarcity of specialized personnel capable of managing complex method development and validation, creating operational bottlenecks and increasing costs for service providers.

Market Overview
Forecast Period	2027-2031
Market Size 2025	USD 761.39 Million
Market Size 2031	USD 1257.37 Million
CAGR 2026-2031	8.72%
Fastest Growing Segment	Capsule
Largest Market	North America

Market Driver

The market is primarily driven by escalating pharmaceutical R&D investments and an expanding drug pipeline, which significantly increases the volume of compounds requiring solubility and release-rate profiling. In 2024, PhRMA member companies invested approximately $100 billion in R&D, contributing to a high volume of new drug approvals, such as the 50 novel drugs approved by the FDA in 2024, all necessitating extensive dissolution data for quality assurance. Furthermore, the proliferation of generic drugs and stringent bioequivalence requirements are key propellers, as dissolution testing serves as a critical surrogate for in vivo bioequivalence studies, ensuring generic formulations perform identically to innovator products. With generics and biosimilars accounting for 90% of U.S. prescriptions in 2025, there is a vast and continuous demand for comparative dissolution testing to support regulatory applications and maintain post-market batch consistency.

Market Challenge

The primary challenge impeding the Global Pharmaceutical Dissolution Testing Services Market's growth is the acute scarcity of specialized personnel capable of executing complex analytical procedures. Dissolution testing demands highly trained analysts to design, validate, and interpret method development protocols, tasks that cannot be simply automated. This talent gap creates severe operational bottlenecks, limiting production capacity and forcing service providers to extend project timelines or decline new contracts, thereby stalling market expansion. Industry data from the Pistoia Alliance in 2025 indicated that 34% of life sciences organizations identified the lack of skilled personnel as a significant barrier to laboratory operations, highlighting a widening gap between technical requirements and available talent, which also drives up operational costs and diminishes profit margins.

Market Trends

A key trend in the dissolution testing market is the increasing adoption of automated and robotic testing systems, fundamentally altering laboratory workflows to mitigate human error and improve throughput. Service providers are integrating fully automated dissolution apparatuses for tasks from media preparation to sample analysis, a strategic move to optimize efficiency amidst workforce constraints, with 50% of life sciences manufacturers planning increased automation by 2025 according to Rockwell Automation. Concurrently, the application of Artificial Intelligence (AI) and Machine Learning (ML) for predictive modeling is revolutionizing dissolution data utilization, with laboratories increasingly employing AI algorithms to analyze historical datasets and predict release profiles. This accelerates method development and reduces physical testing requirements, leading to more accurate simulations and faster decision-making. The industry's confidence is evident as 77% of life sciences professionals expect to utilize AI technologies within their laboratories over the next two years, signaling a major paradigm shift towards data-driven testing strategies.

Key Market Players

Intertek Group Plc
Avivia BV
Almac Group
Agilent Technologies, Inc.
Catalent, Inc.
Thermofisher Scientific Inc
Charles River Laboratories International Inc.
Cambrex Corp.
Boston Analytical
Pace Life Sciences LLC

Report Scope

In this report, the Global Pharmaceutical Dissolution Testing Services Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Pharmaceutical Dissolution Testing Services Market, By Services Method

In vitro
In vivo

Pharmaceutical Dissolution Testing Services Market, By Dissolution Apparatus

Basket
Paddle
Others

Pharmaceutical Dissolution Testing Services Market, By Dosage Form

Capsule
Tablets
Others

Pharmaceutical Dissolution Testing Services Market, By Region

North America
- United States
- Canada
- Mexico
Europe
- France
- United Kingdom
- Italy
- Germany
- Spain
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
South America
- Brazil
- Argentina
- Colombia
Middle East & Africa
- South Africa
- Saudi Arabia
- UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Pharmaceutical Dissolution Testing Services Market.

Available Customizations:

Global Pharmaceutical Dissolution Testing Services Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

1. Product Overview

1.1. Market Definition
1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Pharmaceutical Dissolution Testing Services Market Outlook

5.1. Market Size & Forecast
- 5.1.1. By Value
5.2. Market Share & Forecast
- 5.2.1. By Services Method (In vitro, In vivo)
- 5.2.2. By Dissolution Apparatus (Basket, Paddle, Others)
- 5.2.3. By Dosage Form (Capsule, Tablets, Others)
- 5.2.4. By Region
- 5.2.5. By Company (2025)
5.3. Market Map

6. North America Pharmaceutical Dissolution Testing Services Market Outlook

6.1. Market Size & Forecast
- 6.1.1. By Value
6.2. Market Share & Forecast
- 6.2.1. By Services Method
- 6.2.2. By Dissolution Apparatus
- 6.2.3. By Dosage Form
- 6.2.4. By Country
6.3. North America: Country Analysis
- 6.3.1. United States Pharmaceutical Dissolution Testing Services Market Outlook
  - 6.3.1.1. Market Size & Forecast
    - 6.3.1.1.1. By Value
  - 6.3.1.2. Market Share & Forecast
    - 6.3.1.2.1. By Services Method
    - 6.3.1.2.2. By Dissolution Apparatus
    - 6.3.1.2.3. By Dosage Form
- 6.3.2. Canada Pharmaceutical Dissolution Testing Services Market Outlook
  - 6.3.2.1. Market Size & Forecast
    - 6.3.2.1.1. By Value
  - 6.3.2.2. Market Share & Forecast
    - 6.3.2.2.1. By Services Method
    - 6.3.2.2.2. By Dissolution Apparatus
    - 6.3.2.2.3. By Dosage Form
- 6.3.3. Mexico Pharmaceutical Dissolution Testing Services Market Outlook
  - 6.3.3.1. Market Size & Forecast
    - 6.3.3.1.1. By Value
  - 6.3.3.2. Market Share & Forecast
    - 6.3.3.2.1. By Services Method
    - 6.3.3.2.2. By Dissolution Apparatus
    - 6.3.3.2.3. By Dosage Form

7. Europe Pharmaceutical Dissolution Testing Services Market Outlook

7.1. Market Size & Forecast
- 7.1.1. By Value
7.2. Market Share & Forecast
- 7.2.1. By Services Method
- 7.2.2. By Dissolution Apparatus
- 7.2.3. By Dosage Form
- 7.2.4. By Country
7.3. Europe: Country Analysis
- 7.3.1. Germany Pharmaceutical Dissolution Testing Services Market Outlook
  - 7.3.1.1. Market Size & Forecast
    - 7.3.1.1.1. By Value
  - 7.3.1.2. Market Share & Forecast
    - 7.3.1.2.1. By Services Method
    - 7.3.1.2.2. By Dissolution Apparatus
    - 7.3.1.2.3. By Dosage Form
- 7.3.2. France Pharmaceutical Dissolution Testing Services Market Outlook
  - 7.3.2.1. Market Size & Forecast
    - 7.3.2.1.1. By Value
  - 7.3.2.2. Market Share & Forecast
    - 7.3.2.2.1. By Services Method
    - 7.3.2.2.2. By Dissolution Apparatus
    - 7.3.2.2.3. By Dosage Form
- 7.3.3. United Kingdom Pharmaceutical Dissolution Testing Services Market Outlook
  - 7.3.3.1. Market Size & Forecast
    - 7.3.3.1.1. By Value
  - 7.3.3.2. Market Share & Forecast
    - 7.3.3.2.1. By Services Method
    - 7.3.3.2.2. By Dissolution Apparatus
    - 7.3.3.2.3. By Dosage Form
- 7.3.4. Italy Pharmaceutical Dissolution Testing Services Market Outlook
  - 7.3.4.1. Market Size & Forecast
    - 7.3.4.1.1. By Value
  - 7.3.4.2. Market Share & Forecast
    - 7.3.4.2.1. By Services Method
    - 7.3.4.2.2. By Dissolution Apparatus
    - 7.3.4.2.3. By Dosage Form
- 7.3.5. Spain Pharmaceutical Dissolution Testing Services Market Outlook
  - 7.3.5.1. Market Size & Forecast
    - 7.3.5.1.1. By Value
  - 7.3.5.2. Market Share & Forecast
    - 7.3.5.2.1. By Services Method
    - 7.3.5.2.2. By Dissolution Apparatus
    - 7.3.5.2.3. By Dosage Form

8. Asia Pacific Pharmaceutical Dissolution Testing Services Market Outlook

8.1. Market Size & Forecast
- 8.1.1. By Value
8.2. Market Share & Forecast
- 8.2.1. By Services Method
- 8.2.2. By Dissolution Apparatus
- 8.2.3. By Dosage Form
- 8.2.4. By Country
8.3. Asia Pacific: Country Analysis
- 8.3.1. China Pharmaceutical Dissolution Testing Services Market Outlook
  - 8.3.1.1. Market Size & Forecast
    - 8.3.1.1.1. By Value
  - 8.3.1.2. Market Share & Forecast
    - 8.3.1.2.1. By Services Method
    - 8.3.1.2.2. By Dissolution Apparatus
    - 8.3.1.2.3. By Dosage Form
- 8.3.2. India Pharmaceutical Dissolution Testing Services Market Outlook
  - 8.3.2.1. Market Size & Forecast
    - 8.3.2.1.1. By Value
  - 8.3.2.2. Market Share & Forecast
    - 8.3.2.2.1. By Services Method
    - 8.3.2.2.2. By Dissolution Apparatus
    - 8.3.2.2.3. By Dosage Form
- 8.3.3. Japan Pharmaceutical Dissolution Testing Services Market Outlook
  - 8.3.3.1. Market Size & Forecast
    - 8.3.3.1.1. By Value
  - 8.3.3.2. Market Share & Forecast
    - 8.3.3.2.1. By Services Method
    - 8.3.3.2.2. By Dissolution Apparatus
    - 8.3.3.2.3. By Dosage Form
- 8.3.4. South Korea Pharmaceutical Dissolution Testing Services Market Outlook
  - 8.3.4.1. Market Size & Forecast
    - 8.3.4.1.1. By Value
  - 8.3.4.2. Market Share & Forecast
    - 8.3.4.2.1. By Services Method
    - 8.3.4.2.2. By Dissolution Apparatus
    - 8.3.4.2.3. By Dosage Form
- 8.3.5. Australia Pharmaceutical Dissolution Testing Services Market Outlook
  - 8.3.5.1. Market Size & Forecast
    - 8.3.5.1.1. By Value
  - 8.3.5.2. Market Share & Forecast
    - 8.3.5.2.1. By Services Method
    - 8.3.5.2.2. By Dissolution Apparatus
    - 8.3.5.2.3. By Dosage Form

9. Middle East & Africa Pharmaceutical Dissolution Testing Services Market Outlook

9.1. Market Size & Forecast
- 9.1.1. By Value
9.2. Market Share & Forecast
- 9.2.1. By Services Method
- 9.2.2. By Dissolution Apparatus
- 9.2.3. By Dosage Form
- 9.2.4. By Country
9.3. Middle East & Africa: Country Analysis
- 9.3.1. Saudi Arabia Pharmaceutical Dissolution Testing Services Market Outlook
  - 9.3.1.1. Market Size & Forecast
    - 9.3.1.1.1. By Value
  - 9.3.1.2. Market Share & Forecast
    - 9.3.1.2.1. By Services Method
    - 9.3.1.2.2. By Dissolution Apparatus
    - 9.3.1.2.3. By Dosage Form
- 9.3.2. UAE Pharmaceutical Dissolution Testing Services Market Outlook
  - 9.3.2.1. Market Size & Forecast
    - 9.3.2.1.1. By Value
  - 9.3.2.2. Market Share & Forecast
    - 9.3.2.2.1. By Services Method
    - 9.3.2.2.2. By Dissolution Apparatus
    - 9.3.2.2.3. By Dosage Form
- 9.3.3. South Africa Pharmaceutical Dissolution Testing Services Market Outlook
  - 9.3.3.1. Market Size & Forecast
    - 9.3.3.1.1. By Value
  - 9.3.3.2. Market Share & Forecast
    - 9.3.3.2.1. By Services Method
    - 9.3.3.2.2. By Dissolution Apparatus
    - 9.3.3.2.3. By Dosage Form

10. South America Pharmaceutical Dissolution Testing Services Market Outlook

10.1. Market Size & Forecast
- 10.1.1. By Value
10.2. Market Share & Forecast
- 10.2.1. By Services Method
- 10.2.2. By Dissolution Apparatus
- 10.2.3. By Dosage Form
- 10.2.4. By Country
10.3. South America: Country Analysis
- 10.3.1. Brazil Pharmaceutical Dissolution Testing Services Market Outlook
  - 10.3.1.1. Market Size & Forecast
    - 10.3.1.1.1. By Value
  - 10.3.1.2. Market Share & Forecast
    - 10.3.1.2.1. By Services Method
    - 10.3.1.2.2. By Dissolution Apparatus
    - 10.3.1.2.3. By Dosage Form
- 10.3.2. Colombia Pharmaceutical Dissolution Testing Services Market Outlook
  - 10.3.2.1. Market Size & Forecast
    - 10.3.2.1.1. By Value
  - 10.3.2.2. Market Share & Forecast
    - 10.3.2.2.1. By Services Method
    - 10.3.2.2.2. By Dissolution Apparatus
    - 10.3.2.2.3. By Dosage Form
- 10.3.3. Argentina Pharmaceutical Dissolution Testing Services Market Outlook
  - 10.3.3.1. Market Size & Forecast
    - 10.3.3.1.1. By Value
  - 10.3.3.2. Market Share & Forecast
    - 10.3.3.2.1. By Services Method
    - 10.3.3.2.2. By Dissolution Apparatus
    - 10.3.3.2.3. By Dosage Form

11. Market Dynamics

11.1. Drivers
11.2. Challenges

12. Market Trends & Developments

12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments

13. Global Pharmaceutical Dissolution Testing Services Market: SWOT Analysis

14. Porter's Five Forces Analysis

14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products

15. Competitive Landscape

15.1. Intertek Group Plc
- 15.1.1. Business Overview
- 15.1.2. Products & Services
- 15.1.3. Recent Developments
- 15.1.4. Key Personnel
- 15.1.5. SWOT Analysis
15.2. Avivia BV
15.3. Almac Group
15.4. Agilent Technologies, Inc.
15.5. Catalent, Inc.
15.6. Thermofisher Scientific Inc
15.7. Charles River Laboratories International Inc.
15.8. Cambrex Corp.
15.9. Boston Analytical
15.10. Pace Life Sciences LLC